Zhong Yan-Ping, Chen Hao, Zhou Dan, Zou Hong-Yan
Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen 518020, Guangdong Province, China.
Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen 518020, Guangdong Province, China E-mail:
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Aug;30(4):1213-1218. doi: 10.19746/j.cnki.issn.1009-2137.2022.04.038.
Three cases of rare alleles of HLA-C with zero mismatched PCR-SBT results were analyzed by full-length sequencing to determine the true genotypes.
Three rare HLA-C alleles with zero mismatched PCR-SBT results were screened from clinical transplant matching samples, and the full-length sequence was detected by next-generation sequencing technology.
The results of PCR-SBT typing of 3 samples were: HLA-C03:04, 12:167; HLA-C07:291, 15:02; HLA-C01:43, 08:16. Other alleles were not in the CWD table of common and confirmed HLA alleles in China (version 2.3) except common allele HLA-C03:04, HLA-C15:02. NGS full-length sequencing revealed that the HLA-C genotypes of the three samples were a combination of common alleles and novel alleles, and the three novel alleles had a base mutation in exons 6, 2, and 4, respectively. The novel allele sequences have been submitted to the Genbank database (MK629722, MK335474, MK641803), which were officially named HLA-C03:04:74, HLA-C15:192, HLA-C08:01:25 by the WHO HLA Nomenclature Committee. The HLA high-resolution typing results of 3 samples were: HLA-C03:04:74, HLA-C12:03; HLA-C07:02, HLA-C15:192; HLA-C01:02, HLA-C08:01:25.
HLA typing results containing rare alleles should be treated cautiously, and the full-length sequence should be verified by NGS or cloning. The laboratory finally confirmed that the 3 cases of PCR-SBT zero mismatch HLA-C genotypes are the combination of common alleles and novel alleles by NGS sequencing, which provides an accurate basis for clinical transplantation matching and enriches the human HLA genetic database.
对3例PCR-SBT结果零错配的HLA-C罕见等位基因进行全长测序分析,以确定其真实基因型。
从临床移植配型样本中筛选出3例PCR-SBT结果零错配的罕见HLA-C等位基因,采用二代测序技术检测其全长序列。
3份样本的PCR-SBT分型结果分别为:HLA-C03:04, 12:167;HLA-C07:291, 15:02;HLA-C01:43, 08:16。除常见等位基因HLA-C03:04、HLA-C15:02外,其他等位基因均不在中国常见及确认的HLA等位基因CWD表(2.3版)中。NGS全长测序显示,3份样本的HLA-C基因型均为常见等位基因与新等位基因组成,3个新等位基因分别在外显子6、2和4发生了碱基突变。新等位基因序列已提交至Genbank数据库(MK629722、MK335474、MK641803),经世界卫生组织HLA命名委员会正式命名为HLA-C03:04:74、HLA-C15:192、HLA-C08:01:25。3份样本的HLA高分辨率分型结果分别为:HLA-C03:04:74、HLA-C12:03;HLA-C07:02、HLA-C15:192;HLA-C01:02、HLA-C08:01:25。
对于包含罕见等位基因的HLA分型结果应谨慎对待,需采用NGS或克隆技术对全长序列进行验证。本实验室通过NGS测序最终确认3例PCR-SBT零错配的HLA-C基因型为常见等位基因与新等位基因的组合,为临床移植配型提供了准确依据,丰富了人类HLA基因数据库。